Method for preparing linaclotide
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HYBIO PHARMA
- Publication Date
- 2014-03-12
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of drug synthesis, in particular to a preparation method of linaclotide. Background technique
[0002] Linaclotide, the English name is Linaclotide; the trade name is Linzess; the Chinese common name is Linaclotide. It is a GC-C (intestinal cell uridine cyclase C) receptor agonist, approved by the US FDA in August 2012 for the treatment of adults with chronic idiopathic constipation and constipation-predominant irritable bowel syndrome (IBS) -C). The drug was developed by Ironwood Pharmaceuticals. The compound structure is a polypeptide composed of 14 amino acids containing three pairs of disulfide bonds (the three pairs of disulfide bonds are: 1-6; 2-10 and 5-13), which can be expressed by cells and chemical synthesis, the specific peptide sequence is shown in the following formula:
[0003]
[0004] At present, there is no relatively efficient preparation method for linaclotide, and there are no rele...